← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 30, 2021Last known activity
Oct 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 8 trials)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Recent trials (10)
- NCT05900401CollaboratorPhase 1/Phase 2Oct 1, 2023
- NCT05443464Lead sponsorPhase 1Jun 5, 2023
- NCT05443464Study directorPhase 1Jun 5, 2023
- NCT05589896Lead sponsorPhase 1/Phase 2Mar 31, 2023
- NCT05407766Study directorPhase 1Aug 31, 2022
- NCT05407766Lead sponsorPhase 1Aug 31, 2022
- NCT05170828Lead sponsorPhase 1Mar 31, 2022
- NCT05068401CollaboratorPhase 1Mar 31, 2022
- NCT05075811CollaboratorPhase 1/Phase 2Nov 15, 2021
- NCT04804891CollaboratorPhase 1Sep 30, 2021
Details
- Last known activity
- Oct 1, 2023